FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+11.73%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$239M
AUM Growth
+$239M
(+18%)
Cap. Flow
+$20.4M
Cap. Flow
% of AUM
8.54%
Top 10 Holdings %
Top 10 Hldgs %
46.71%
Holding
69
New
7
Increased
14
Reduced
22
Closed
4
Top Buys
| 1 |
AMED
Amedisys
AMED
|
$5.75M |
| 2 |
ELGX
Endologix Inc
ELGX
|
$5.17M |
| 3 |
LDRH
LDR HOLDINGS CORP COM STK
LDRH
|
$4.45M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$4.05M |
| 5 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
$3.46M |
Top Sells
| 1 |
Omnicell
OMCL
|
$5.36M |
| 2 |
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
|
$3.93M |
| 3 |
Bio-Techne
TECH
|
$2.68M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
$1.93M |
| 5 |
Esperion Therapeutics
ESPR
|
$1.13M |
Sector Composition
| 1 | Healthcare | 77.26% |
| 2 | Energy | 3.08% |
| 3 | Real Estate | 2.24% |
| 4 | Financials | 0.24% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Veracyte
VCYT
$2.41B
| $3.84M | 1.61% |
532,574
-32,358
| -6% | -$233K |
|
|
MDCO
27
DELISTED
Medicines Co
MDCO
| $3.5M | 1.46% |
93,656
+9,553
| +11% | +$357K |
|
|
EVHC
28
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $3.46M | 1.45% |
+133,187
| New | +$3.46M |
|
29
Celldex Therapeutics
CLDX
$1.57B
| $3.27M | 1.37% |
208,343
-6,794
| -3% | -$106K |
|
30
AngioDynamics
ANGO
$432M
| $3.18M | 1.33% |
262,089
-15,234
| -5% | -$185K |
|
31
Vertex Pharmaceuticals
VRTX
$102B
| $3.06M | 1.28% |
24,320
-323
| -1% | -$40.6K |
|
32
Arrowhead Research
ARWR
$3.84B
| $2.85M | 1.19% |
463,140
-2,363
| -0.5% | -$14.5K |
|
|
IMMU
33
DELISTED
Immunomedics Inc
IMMU
| $2.61M | 1.09% |
+850,757
| New | +$2.61M |
|
34
HealthStream
HSTM
$832M
| $2.57M | 1.08% |
117,006
-1,346
| -1% | -$29.6K |
|
|
STRM
35
DELISTED
Streamline Health Solutions
STRM
| $2.45M | 1.03% |
1,739,045
+483,897
| +39% | +$682K |
|
|
ARRY
36
DELISTED
Array Biopharma Inc
ARRY
| $2.24M | 0.94% |
530,391
-458,198
| -46% | -$1.93M |
|
|
37
Bio-Techne
TECH
$8.3B
| $2.21M | 0.93% |
24,556
-29,730
| -55% | -$2.68M |
|
|
PETX
38
DELISTED
Aratana Therapeutics, Inc.
PETX
| $2.2M | 0.92% |
395,043
+312,132
| +376% | +$1.74M |
|
|
CPHD
39
DELISTED
Cepheid Inc
CPHD
| $2.18M | 0.91% |
59,691
-4,580
| -7% | -$167K |
|
40
Karyopharm Therapeutics
KPTI
$61.4M
| $2.02M | 0.85% |
152,765
-1,945
| -1% | -$25.8K |
|
41
BioMarin Pharmaceuticals
BMRN
$11.3B
| $1.98M | 0.83% |
18,901
-252
| -1% | -$26.4K |
|
|
AGN
42
DELISTED
Allergan plc
AGN
| $636K | 0.27% |
2,035
| – | – |
|
43
Humana
HUM
$37.5B
| $632K | 0.26% |
3,540
| – | – |
|
44
United Therapeutics
UTHR
$17.7B
| $598K | 0.25% |
3,820
| – | – |
|
45
Elevance Health
ELV
$72.4B
| $571K | 0.24% |
4,095
| – | – |
|
46
Bristol-Myers Squibb
BMY
$96.7B
| $570K | 0.24% |
8,290
| – | – |
|
|
AET
47
DELISTED
Aetna Inc
AET
| $564K | 0.24% |
5,215
| – | – |
|
48
Viatris
VTRS
$12.3B
| $529K | 0.22% |
9,775
| – | – |
|
49
Becton Dickinson
BDX
$54.3B
| $523K | 0.22% |
3,395
| – | – |
|
50
Novartis
NVS
$248B
| $522K | 0.22% |
6,070
| – | – |
|